ArticleNPJ systems biology and applications2026
Bulk transcriptomics of peripheral blood mononuclear cells delineates systems-level immune dysregulation in pediatric dengue infection.
Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Children are disproportionately at a greater risk of developing severe dengue disease, yet the molecular mechanisms driving the heightened susceptibility remains poorly understood. To elucidate the immune determinants of pediatric dengue pathogenesis, we profiled the transcriptomic landscape by performing RNA sequencing (RNA-Seq) on peripheral blood mononuclear cells (PBMCs) from laboratory-confirmed cases of primary and secondary pediatric dengue, as well as pediatric healthy controls. Differential gene expression (DEG) and pathway analyses were performed to delineate the transcriptional alterations. Pediatric dengue was marked by extensive transcriptional changes with altered expression of genes associated with the complement cascade macrophage-associated genes as well as immune checkpoint molecules. Notably, secondary infection had significant alterations in immune checkpoint molecules and genes associated with macrophage activation, suggesting the onset of immune exhaustion during reinfection. Differences between the primary and secondary dengue cohorts were modest relative to the transcriptional differences observed between either of the groups and healthy controls, with immune checkpoint genes showing the most consistent divergence between the two dengue cohorts. While our initial findings provide early insights into the transcriptional patterns potentially associated with disease outcomes, the dysregulated transcriptomic signatures reported here are preliminary requiring systemic functional validation to determine their biologic role in the immunopathogenesis of pediatric dengue infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.